Neonatal Erythropoietin And Therapeutic Hypothermia Outcomes in Newborn Brain Injury (NEATO) (NEATO)
Neonatal Erythropoietin And Therapeutic Hypothermia Outcomes Study
Sponsor: Arkansas Children's Hospital Research Institute
This PHASE1/PHASE2 trial investigates Birth Asphyxia and Hypoxic-ischemic Encephalopathy and is currently completed. Arkansas Children's Hospital Research Institute leads this study, which shows 10 recorded versions since 2013 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
10 versions recorded-
Sep 2025 — Present [monthly]
Completed PHASE1/PHASE2
-
Sep 2024 — Sep 2025 [monthly]
Completed PHASE1/PHASE2
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE1/PHASE2
Phase: PHASE1_PHASE2 → PHASE1/PHASE2
-
Jan 2021 — Jul 2024 [monthly]
Completed PHASE1_PHASE2
-
Aug 2020 — Jan 2021 [monthly]
Completed PHASE1_PHASE2
Status: Unknown Status → Completed
▶ Show 5 earlier versions
-
Mar 2020 — Aug 2020 [monthly]
Unknown Status PHASE1_PHASE2
-
Jun 2018 — Mar 2020 [monthly]
Unknown Status PHASE1_PHASE2
-
Apr 2018 — Jun 2018 [monthly]
Unknown Status PHASE1_PHASE2
Status: Active Not Recruiting → Unknown Status
-
Feb 2017 — Apr 2018 [monthly]
Active Not Recruiting PHASE1_PHASE2
-
Jan 2017 — Feb 2017 [monthly]
Active Not Recruiting PHASE1_PHASE2
First recorded
Sep 2013
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Arkansas Children's Hospital Research Institute
- Children's National Research Institute
- Kaiser Permanente
- Seattle Children's Hospital
- Stanford University
- Thrasher Research Fund
- University of California, San Francisco
- Washington University School of Medicine
For direct contact, visit the study record on ClinicalTrials.gov .